Skip to main content
. 2018 Aug 23;24(2):143–145. doi: 10.1634/theoncologist.2018-0443

Table 1. Phase III clinical trials of novel combination regimens for first‐line therapy for metastatic renal cell carcinoma.

image

a

Primary completion date: The date on which the last participant in the clinical study was examined or received an intervention to collect final data for the primary outcome measure.

Abbreviations: OS, overall survival; PFS, progression‐free survival.